# A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients

> **NCT03977207** · NA · RECRUITING · sponsor: **University of California, Irvine** · enrollment: 336 (estimated)

## Conditions studied

- Thyroid; Functional Disturbance
- Hypothyroidism
- Hemodialysis

## Interventions

- **DRUG:** Levothyroxine Sodium
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03977207
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-07-20
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 336 (ESTIMATED)
- **Last updated:** 2025-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03977207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03977207, "A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT03977207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*